Stocks · Technology · Laboratory Analytical Instruments

EyePoint, Inc.

EYPT Clue Score33
United States Fiscal year ends December CIK 0001314102 Results filed 19 Oct 2026

What the insiders did Balanced

Insider
Date
Role
Action
Shares
Price
Amount
Nancy Lurker
4 Dec 2025
Director
Sold on a plan
9,300
$15.11
$140.48K
Nancy Lurker
28 Nov 2025
Director
Sold on a plan
500
$14.95
$7.48K
Nancy Lurker
26 Nov 2025
Director
Sold on a plan
200
$14.95
$2.99K
Ramiro Ribeiro
11 Nov 2025
Chief Medical Officer
Sold on a plan
2,722
$11.61
$31.60K
Nancy Lurker
24 Jan 2024
Executive Vice Chair
Sold on a plan
29,956
$24.98
$748.25K
Nancy Lurker
23 Jan 2024
Executive Vice Chair
Sold on a plan
5,044
$24.97
$125.95K
Nancy Lurker
4 Dec 2023
Executive Vice Chair
Sold on a plan
20,000
$20.76
$415.20K

What was left out

Form 4 filings counted 312
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 13
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 33
Sales at will 22
Transactions with no price 0
Shares from compensation/vesting 3,676,102
Sales filed before the plan box existed 1
History held since 22 Oct 2007